Joseph R. Taylor

Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes

Wei Meng, Bruce A. Ellsworth, Alexandra A. Nirschl et al. · Journal of Medicinal Chemistry · 2008 · 612 citations · Full text

Metabolic Syndrome, Diabetes Management, Biochemistry +10

Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats

Song‐Ping Han, Deborah Hagan, Joseph R. Taylor et al. · Diabetes · 2008 · 416 citations · Full text

Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses

John E. Wolf, Joseph R. Taylor, Eduardo Tschen et al. · International Journal of Dermatology · 2001 · 239 citations · Full text

Novel Benzofuran and Benzothiophene Biphenyls as Inhibitors of Protein Tyrosine Phosphatase 1B with Antihyperglycemic Properties

Michael S. Malamas, Janet Sredy, Christopher Moxham et al. · Journal of Medicinal Chemistry · 2000 · 210 citations · Full text

Benzofuran/benzothiophene Biphenyl Framework, Chemical Biology, Pharmaceutical Chemistry +18

Eleven Amino Acid Glucagon-like Peptide-1 Receptor Agonists with Antidiabetic Activity

Claudio Mapelli, Sesha Natarajan, Jean‐Philippe Meyer et al. · Journal of Medicinal Chemistry · 2009 · 70 citations · Full text

Metabolic Syndrome, Diabetes Management, Peptides 21 +15